13.09.2016 – Diabetes major Sanofi is joining forces with Verily – formerly Google Life Sciences – to launch Onduo. The joint venture will develop a comprehensive diabetes management platform.
ADVERTISEMENT
09.09.2016 – iBionexts healthcare VC fund iBionext Growth has announced a first closing of €46m. All in all, iBionext aims to take in around €100m to reinvest in biotech and medtech companies.
French biopharma company Pharnext has appointed René Goedkoop as its new Chief Medical Officer. He joins the neurodegenerative disease specialist from Swiss Shogu Consulting SarL.
07.09.2016 – Furniture giant Ikea and renewables expert Neste have joined forces to deliver bio-based plastics based on Neste’s bio-based polymer. The partners urge other companies to join the initiative.
06.09.2016 – DBVs needle-free patch technology is being put to the test in a a proof of concept trial for a pertussis vaccine developed by BioNet-Asia. Researchers from the Geneva University Hospital are supervising the study.
Matthias Schroff, erstwhile CEO of Mologen, has taken over the helm of immunotherapy developer Vaximm AG. The Swiss-German company appointed him Chief Executive Officer in early September.
05.09.2016 – Why do people grow old? Italian researchers took a close look at centenarians and found that low levels of the peptide hormone Adrenomedullin may significantly contribute towards good microcirculation and thus longevity.
Swedish clinical-stage biopharmaceutical company Aprea AB has named Christian Schade President and Chief Executive Officer. Before joining Aprea, Schade was CEO of US antiviral developer Novira Therapeutics, which was acquired by Johnson & Johnson last December.
01.09.2016 – The causes of Alzheimer’s disease are still largely unknown. But now, an antibody developed by the University of Zurich has significantly reduced the brain amyloid plaques typical for Alzheimers Disease in a Phase Ib clinical trial.